These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37125743)

  • 1. Comparison of Doxycycline or Minocycline to Sulfamethoxazole-Trimethoprim for Treatment of
    Alhayani T; Philpott CD; Liao S; Gentene AJ; Mueller EW
    Ann Pharmacother; 2024 Jan; 58(1):21-27. PubMed ID: 37125743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
    Junco SJ; Bowman MC; Turner RB
    Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections.
    Tekçe YT; Erbay A; Cabadak H; Sen S
    J Chemother; 2012 Jun; 24(3):150-4. PubMed ID: 22759759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
    Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
    Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
    Hand E; Davis H; Kim T; Duhon B
    J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
    Hevia EC; Wooten L; Carr AL
    Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant
    Wu J; Zhang G; Zhao Q; Wang L; Yang J; Cui J
    Infect Drug Resist; 2023; 16():6005-6015. PubMed ID: 37705512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z; Qin J; Liu Y; Li C; Ying C
    BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: a high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use.
    Huang CR; Chen SF; Tsai NW; Chang CC; Lu CH; Chuang YC; Chien CC; Chang WN
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1709-15. PubMed ID: 23611735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant
    Hong J; Ensom MHH; Lau TTY
    Ann Pharmacother; 2019 Nov; 53(11):1153-1161. PubMed ID: 31177803
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits.
    Petraitis V; Petraitiene R; Kavaliauskas P; Naing E; Garcia A; Georgiades BN; Echols R; Bonomo RA; Yamano Y; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0061822. PubMed ID: 36154614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
    Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
    Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study.
    Almangour TA; Alkherb Z; Alruwaite S; Alsahli R; Alali H; Almohaizeie A; Almuhisen S; Alowais SA; Saleh KB; Fetyani L; Alnashmi F; Alghofaily A; Abouobaid NI; Binkhamis KM; Tawfik EA; Alsowaida YS
    J Glob Antimicrob Resist; 2024 Sep; 38():42-48. PubMed ID: 38821443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophilia.
    Kunz Coyne AJ; Herbin S; Caniff K; Rybak MJ
    Pharmacotherapy; 2023 Aug; 43(8):833-846. PubMed ID: 37199104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX; Yu CM; Hsu ST; Wang CH
    J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
    Demirbuğa A; Akgün Karapınar DB; Yaşa B; Çoban A; Öngen B; Dede E; Mete Atasever N; Somer A; Hançerli Törün S
    Pediatr Neonatol; 2024 Mar; 65(2):183-187. PubMed ID: 37919104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis.
    Lee YL; Hsueh PR
    Curr Opin Infect Dis; 2023 Dec; 36(6):481-494. PubMed ID: 37548375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.